Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, 3/10 January 2015, Vol 294, No 7843/4

Sort by: Newest first Oldest first A-Z Z-A

  • A rethink is needed about how medicines-related IT systems should work

    1 DEC 2014 By Andrew Davies
    Comments (2)

    Current initiatives to roll out patient record access to pharmacy provide insufficient patient information, and lack functionalities to ensure safe and efficient provision of services to patients. Moreover, access to these records have been patchy and wider access is needed, writes Andrew Davies.

  • Afinitor side effects Subscription

    18 DEC 2014 10:54

    Irregular menstruation is now listed as a common side effect, and amenorrhea is now listed as an uncommon side effect, on the summary of product characteristics for Afinitor (everolimus; Novartis).

  • Alcohol and substance misuse Subscription

    12 DEC 2014 12:29

    As part of the Health and Social Care Committee inquiry into alcohol and substance misuse in Wales, the Committee will consider the following areas: The impacts of alcohol and substance misuse on people in Wales, including young people and university students, older people, homeless people, and people in police custody or prisons; The ...

  • Carmen Peña, president of the International Pharmaceutical Federation (FIP)

    An advocate for global pharmacy Subscription

    7 JAN 2015 18:03 By Benedict Lam

    President of the International Pharmaceutical Federation Carmen Peña discusses gender equality, fighting Ebola and her vision for advanced roles for pharmacists.

  • Antipsychotics are being used for anxiety and dementia, despite licensed indications Subscription

    19 DEC 2014 15:26

    A large proportion of people prescribed antipsychotics do not have a diagnosis of psychosis or bipolar disorder, research indicates.

  • Molecular ruler

    Bacteria’s protein machinery may offer antibiotic target Subscription

    18 DEC 2014 16:58 By Mark Peplow

    Researchers have unveiled a snapshot of the molecular machinery that bacteria use to build polysaccharide chains that protect them from immune attack.

  • Calpol skin reactions Subscription

    18 DEC 2014 10:44

    The summary of product characteristics for Calpol (paracetamol; McNeil) infant oral suspension now states that patients should be informed about the signs of serious skin reactions, and use of the drug should be discontinued at the first appearance of skin rash or any other sign of hypersensitivity. 

  • Care standards in Wales Subscription

    12 DEC 2014 12:29

    The Welsh Government is consulting on integrating the 26 Standards for Health Services in Wales and the 12 Fundamentals of Care Standards into 7 Quality Themes and 24 Health Standards. Full details of this consultation can be found on the Welsh Government website.

  • Carfilzomib gives survival benefits to patients with relapsed multiple myeloma (pictured)

    Carfilzomib gives survival benefits to patients with relapsed multiple myeloma Subscription

    18 DEC 2014 14:56

    Adding the proteasome inhibitor carfilzomib to lenalidomide plus dexamethasone, the standard treatment for patients with relapsed multiple myeloma, significantly improves outcomes.

  • Caution is needed with e-cigarettes Subscription

    15 DEC 2014 14:13 By Paul Hardy
    Comments (2)

    In 2013, the World Health Organization (WHO) published a report on electronic nicotine delivery systems (ENDS), known as e-cigarettes. The working party responsible showed less enthusiasm than Margaret Cunningham (The Pharmaceutical Journal 2014;293:599). ...

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.